Physician profile
Eric J Chou
NPI 1982690772
$4,164.18
in general payments reported to CMS, 2019-2025
20 companies · $94.01 in 2025
The $94.01 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,539 · 2020: $303 · 2021: $654 · 2022: $717 · 2023: $722 · 2024: $135 · 2025: $94.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,858.11 | 2019-2023 | Avvigo Guidance System, Rotablator Rotational Atherectomy System Console Kit |
| Abiomed | $1,104.90 | 2019-2024 | Impella |
| Abbott Laboratories | $181.04 | 2021-2023 | Mitraclip |
| Janssen Pharmaceuticals, INC | $169.26 | 2021-2024 | Xarelto |
| Livanova USA, INC. | $161.19 | 2021-2023 | Lifesparc |
| Akcea Therapeutics, INC. | $125.00 | 2019 | |
| Asahi Intecc USA, INC. | $118.57 | 2021 | |
| Getinge USA Sales, LLC | $102.20 | 2023 | Cardiohelp |
| Pfizer INC. | $92.76 | 2021-2025 | |
| Cardiovascular Systems INC. | $42.26 | 2023 | Diamondback Coronary |
| Penumbra, INC. | $35.74 | 2025 | Penumbra System |
| Amgen INC. | $29.26 | 2019 | |
| Cordis US Corp. | $27.15 | 2023 | Mynx Control, Mynxgrip |
| W. L. Gore & Associates, INC. | $21.94 | 2023 | Gore Cardioform Septal Occluder |
| Teleflex LLC | $21.51 | 2023 | Twin-Pass |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19.81 | 2025 | Spiderfx |
| Philips North America LLC | $14.87 | 2021 | |
| Angiodynamics, INC. | $14.74 | 2024 | Alphavac |
| E.R. Squibb & Sons, L.L.C. | $11.95 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Chou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.